NCATS

  • -
    The CTSA Program Annual Spring Meeting provides an opportunity for the CTSA Steering Committee, Communicators Group, and Enterprise Committees to convene in person to support their goals, address priority or emerging public health issues, and share and/or define best practices across the consortium. Each group sets their own agenda for this meeting.
  • Jump to: Dr. Sacco's Remembrance Dr. Smyth's Remembrance Dr. Supinksi's Remembrance We are saddened to share the news of the recent losses of our colleagues and friends in the CTSA community, Drs. Ralph Sacco, Susan Smyth, and Gerald Supinski, following the loss of Dr. Rebecca Jackson earlier in 2022. In remembrance of these remarkable physician-scientist giants in the CTSA community, we encourage
  • National Institutes of Health
    -
    National Institutes of Health
    Rare Disease Day®(link is external) takes place worldwide, typically on or near the last day of February each year, to raise awareness among policymakers and the public about rare diseases and their impact on patients’ lives. Since 2011, NCATS and the NIH Clinical Center have sponsored Rare Disease Day at NIH as part of this global observance. Rare Disease Day at NIH aims to raise awareness about
  • At the beginning of this month, nearly 400 people gathered in person for our annual fall CTSA Program Meeting, marking the first time we were able to hold the meeting in person in three years. If you were unable to attend, the top ten takeaways from the meeting, which were presented by Mike Kurilla, M.D., Ph.D., director of the Division of Clinical Innovation at NCATS, and Laura James, M.D
  • The NCATS Translational Science Principles are a new resource that summarizes key approaches for accelerating progress along the translational pipeline toward solutions to improve human health. The principles complement the 2011 CTSA Education Core Competency Work Group’s 14 Core Competencies in Clinical and Translational Research, while drawing the focus to knowledge, skills, and attitudes
  • I-Corps@NCATS Regional Short Course: Learn a new approach to taking your research from the lab to the clinic from experts in this free, 5-week, online course. Apply by October 3. Photos of course instructors: David Ellers, Syracuse University; Mark W. Wilson, MS, Simon Business School; Nate Hafer, PhD, UMass Medical School
    -
    University Of Rochester
    The University of Rochester Clinical and Translational Science Institute and Ain Center for Entrepreneurship and Innovation are hosting an I-Corps@NCATS Regional Short Course this fall, specifically designed to provide biomedical scientists, clinician scientists, and engineers with a new approach to accelerate the translation of their discoveries from the lab to clinical practice. This program
  • NCATS collaborate innovate celebrate
    -
    NCATS
    Registration is now open for the Assay Guidance Workshop for High-Throughput Screening and Lead Discovery that will be held in-person on October 18-19, 2022 at the Porter Neuroscience Research Center (Building 35A), NIH Main Campus, Bethesda, MD. This event is free to register. This workshop includes speakers from pharma, biotech, government and academia. Presentations cover a wide range of topics
  • In the additional documents from the May 9th CTSA Program Steering Committee Meeting you will find the DEI Task Force (TF) Summary Document for the Consortium. This document includes the DEI TF charge, the CTSA DEI Learning System Framework as well as the TF’s recommendations in the four focus areas discussed by L. Ebony Boulware, MD, et al. in their perspective piece, Combating Structural
  • Omni Hotel
    -
    Meeting Theme: Achieving Health Equity through the Science of Translation
  • blue color with honeycomb design in the bottom left corner featuring icons
    -

    NCATS Rapid Response Un-Meeting

    Moving scientific discoveries into the “real world” effectively, efficiently, and safely are core principles of translational science. With the advent of big data analytics and data derived from multiple sources, it has become increasingly clear that utilizing data from real-world contexts opens another key layer of the translational science process.

  • In the recent Journal of Clinical and Translational Sciences (JCTS) thematic issue on Entrepreneurship and Innovation, institutions showcase their experience, approaches, and findings in the area of innovation and academic entrepreneurship. Translating innovations into improved human health reflects NCATS’ mission and the goals of the CTSA Program. Through the CTSA Program, hubs work tirelessly to
  • NCATS Logo
    -
    NCATS

    The CTSA Visiting Scholar program consists of giving the virtual CTSA Grand Rounds lecture, which is open to the entire CTSA Consortium, and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers. There are two main goals of this program. The first is to offer the opportunity to serve as a visiting professor and help make connections with faculty that will

  • Headshots of Hua Xu, Frank Manion, and Pablo Cure
    -
    NCATS
    Join NCATS SBIR/STTR and CTSA awardee company Melax Tech for a panel discussion hosted by Lili Portilla, M.P.A. Learn how Melax Tech successfully leveraged the SBIR grant in the development of their natural language processing technology with additional support from the CTSA program.
  • The two meetings held each year provide an opportunity to achieve the CTSA Program Goals and bring key consortium stakeholders together. The CTSA Program Annual Meeting is held in the fall focusing on priority areas and offering opportunities for the consortium members to come together to share best practices.The agenda for this meeting is planned by the CTSA Program Steering Committee with input received from prior meeting evaluations and additional input solicited from the consortium.
  • -
    The two meetings held each year provide an opportunity to achieve the CTSA Program Goals and bring key consortium stakeholders together. The CTSA Program Annual Meeting is held in the fall focusing on priority areas and offering opportunities for the consortium members to come together to share best practices.The agenda for this meeting is planned by the CTSA Program Steering Committee with input received from prior meeting evaluations and additional input solicited from the consortium.
  • Harnessing NCATS SBIR/STTR Funding to Support Commercialization for Innovations in Translational Sciences - Wednesday, October 27th, 2021, 1:00 – 2:00 p.m. ET
    -
    NCATS
    Harnessing NCATS SBIR/STTR Funding to Support Commercialization for Innovations in Translational Sciences Wednesday, October 27th, 2021, 1:00 – 2:00 p.m. ET Join Medical University of South Carolina (MUSC) in collaboration with the National Center for Advancing Translational Sciences (NCATS) on Wednesday, October 27, 2021, for a webinar to learn about the Small Business Innovation Research and
  • The NCATS Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs help foster small business participation in research and development as well as technology commercialization. These programs are engines of innovation, offering grants, contracts and technical assistance to small businesses and academic research organizations. There are many benefits to

  • Addressing the most pressing and complex clinical and translational science problems requires the collective expertise and creativity of a diverse scientific workforce. Studies have shown that diverse teams outperform homogeneous teams,1-3 produce better science,4 and help break down assumptions that persons from certain backgrounds perhaps do not ‘‘fit in’’ or belong in science.5 Indeed, it is
  • NCATS Logo
    -
    NCATS

    NCATS is conducting a technical assistance webinar on Tuesday, September 28, 2021, from 1:00 – 3:00 PM EDT (12PM CDT, 11AM MDT, 10AM PDT) for applicants responding to the Clinical and Translational Science Award (UM1 Clinical Trial Optional) (PAR-21-293). Registration required: register here. All prospective applicants are invited to attend and are highly encouraged to submit questions at least

  • City Scape with lines and orbs above locations implying people connecting to a virtual network
    -
    Meeting Theme: Intentional Disruption and Innovation: The Future of Translational Science Objective: To highlight changes and innovations that CTSA Program consortium hubs had to make during the COVID pandemic; describing the creative innovations developed and what they suggest concerning intentionally causing the disruption and spurring innovative solutions in the post-COVID world.
  • Using an ACTIV master protocol, the trial will focus on potential interventions for mild-to-moderate illness The National Institutes of Health will fund a large, randomized, placebo controlled Phase 3 clinical trial to test several existing prescription and over-the-counter medications for people to self-administer to treat symptoms of COVID-19. Part of the Accelerating COVID 19 Therapeutic
  • NIH National Center for Advancing Translational Sciences
    -
    NCATS

    KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Mathew Cherian MD, from Ohio State University, hosted by the National Center for Advancing Translational Sciences will present his research on "Tolerable Strategies to Overcome Treatment Resistance in Breast Cancer" Resistance to first-line endocrine and cyclin

  • UNIVERSITY OF CALIFORNIA, SAN DIEGO
    -
    University Of California San Diego

    KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Marina Walther-Antonio, PhD from the Mayo Clinic Rochester, hosted by the University of California San Diego will present her research on "The Microbiome Side of Endometrial Cancer.

  • The Translational Science Interagency Fellowship (TSIF) program is jointly sponsored by NCATS and the U.S. Food and Drug Administration (FDA) and aims to provide training in both translational science and regulatory science. The common goal of NCATS and the FDA is to bring safe and effective drugs, regimens and devices from the bench to the bedside as quickly and efficiently as possible. To that

  • The Translational Science Interagency Fellowship (TSIF) is a new postdoctoral fellowship opportunity developed by the National Center for Advancing Translational Sciences (NCATS) and the U.S. Food and Drug Administration (FDA). Fellows will be jointly mentored by NCATS and FDA scientists on a research project of mutual interest to both organizations. Fellows in this program will develop skills of

  • The Center for Clinical & Translational Science will use new grant to help grow the reach of I-Corps@NCATS in order to help scientists translate their discoveries to the marketplace.

  • NCATS Logo
    -
    NCATS

    The NCATS Advisory Council will convene a virtual meeting on Sept. 17, 2020. The meeting will feature presentations by NCATS leadership and invited guests. For more information about the Advisory Council, visit the NCATS Advisory Council page of this site. Closed Session: 10-11 a.m. ET Open Session: 11:30a.m. to 5 p.m. ET

  • NCATS Logo
    -
    NCATS

    During this session, participants will learn about the field of translational science, how NCATS is developing this new field of investigation and opportunities to conduct translational science research in the NCATS intramural (i.e., on-site in Maryland) laboratories. NCATS defines translational science as “an emerging field of investigation focused on identifying and understanding broadly

  • NCATS Logo
    -
    NCATS

    Enhance your translational science skills this summer with a seven-week online course, MEDI 501: Principles of Preclinical Translational Science. This class is open to the public and is being offered by NCATS’ Education Branch in partnership with the Foundation for Advanced Education in the Sciences(link is external). This course has reached capacity for Summer 2020. To receive an invitation to

  • National Institutes of Health
    -
    Center for Data to Health

    Join the Ground Rounds Rethinking Clinical Trial Series with guest speakers: Ken Gersing, MD Director of Informatics, NCATS National Institutes of Health Robert A. Star, MD Director, Division of Kidney, Urologic, and Hematologic Disorders, NIDDK Chief, Renal Diagnostics and Therapeutics Unit, NIDDK National Institutes of Health